Endogenous IL-13 Plays a Crucial Role in Liver Granuloma Maturation During Leishmania donovani Infection, Independent of IL-4Rα–Responsive Macrophages and Neutrophils
Open Access
- 1 July 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 204 (1), 36-43
- https://doi.org/10.1093/infdis/jir080
Abstract
Previous studies comparing interleukin 4 receptor α (IL-4Rα)-/- and interleukin 4 (IL-4)-/- BALB/c mice have indicated that interleukin 13 (IL-13), whose receptor shares the IL-4Rα subunit with IL-4, plays a protective role during visceral leishmaniasis. We demonstrate that IL-13-/- BALB/c mice were less able to control hepatic growth of Leishmania donovani compared with wild-type mice. This correlated with significantly retarded granuloma maturation in IL-13-/- mice, defective interferon γ (IFN-γ) production, and elevated IL-4 and interleukin 10 (IL-10) levels. L.donovani–infected IL-13-/- mice also responded poorly to sodium stibogluconate-mediated chemotherapy compared with wild-type BALB/c mice. Because murine lymphocytes do not have IL-13 receptors, we examined the ability of macrophage/neutrophil-specific IL-4Rα-/- mice to control primary infection with L. donovani and to respond to chemotherapy. Macrophage/neutrophil-specific IL-4Rα-/- mice were as resistant to leishmaniasis as wild-type mice, and chemotherapy retained its efficacy. Consequently, in L. donovani infected BALB/c mice, IL-13 promotes hepatic granuloma formation and controls parasite burdens independently of direct effects on macrophages/neutrophils.Keywords
This publication has 29 references indexed in Scilit:
- Deletion of IL-4Rα on CD4 T Cells Renders BALB/c Mice Resistant to Leishmania major InfectionPLoS Pathogens, 2007
- The Schistosoma mansoni Hepatic Egg Granuloma Provides a Favorable Microenvironment for Sustained Growth of Leishmania donovaniThe American Journal of Pathology, 2006
- Antagonizing Deactivating Cytokines To Enhance Host Defense and Chemotherapy in Experimental Visceral LeishmaniasisInfection and Immunity, 2005
- The immunopathology of experimental visceral leishmaniasisImmunological Reviews, 2004
- Alternative Macrophage Activation Is Essential for Survival during Schistosomiasis and Downmodulates T Helper 1 Responses and ImmunopathologyImmunity, 2004
- The In Vivo Susceptibility of Leishmania donovani to Sodium Stibogluconate Is Drug Specific and Can Be Reversed by Inhibiting Glutathione BiosynthesisAntimicrobial Agents and Chemotherapy, 2003
- Tissue granuloma structure‐function in experimental visceral leishmaniasisInternational Journal of Experimental Pathology, 2001
- Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosisHepatology, 2001
- Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.JCI Insight, 1989
- The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependentJournal of Pharmacy and Pharmacology, 1988